Success Stories: EB-1B Petition Approved for a Senior Director of Research and Development in Texas in the Field of Genomics
We Received EB-1B Approval for a Senior Director of Research and Development in the Field of Genomics on March 23rd, 2015 (Approval Notice)
Position at the Time of Case Filing: Senior Director of Research and Development
Petitioner: A Private Company
Country of Origin: India
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Texas
Approval Notice Date: March 23rd, 2015
Processing Time: 3 months, 18 days
At North America Immigration Law Group, we recently received an EB-1B approval for a Senior Director of Research and Development in the field of genomics. The beneficiary’s outstanding ability, highly skilled background, and impressive record of achievement provided a strong case for her EB-1B petition. Her specialized research has focused on cancer biology and molecular therapeutics. Her research work had resulted in 4 peer-reviewed scientific articles, 11 abstract proceedings/posters, and 5 oral presentations at national and international conferences. The beneficiary had a total of 99 citations to her work by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of her work. The petitioner in this case was a private company. The significance of the beneficiary’s research is confirmed in the following quote by an independent recommender, “In conclusion, [Client’s] research has direct applications to cancer research drug development, and clinical practice. She has emerged as an innovative investigator, that generated important new findings relevant to cancer research…She has gained a place of distinction as a researcher in the field...” It was our goal to prove that this beneficiary qualified for classification as an outstanding professor or researcher given the international recognition for her outstanding achievements. With the proof and documentation that we provided, her case was approved in 3 months and 18 days.

